Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test if the investigational medication, ABT-384, is a safe
and effective treatment for adults with mild-to-moderate Alzheimer's Disease.